Relamp
USPTO PatentsView assignee record - 13 granted patents across 0 technology areas, recorded in grant years 2019–2019. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength.
The verdict
According to USPTO PatentsView, Relamp ranks #21,680 of 49,997 tracked US assignees by granted-patent volume, with 13 patents across 0 technology areas.
- #21,680
- of 49,997 US assignees by volume
- 1st percentile
- by Innovation Score (9.7/100)
- 1.0
- avg claims per patent
- -100%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R21680 · US Corporation #21,680 · 13 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-UNK · INNOV-LOW · CLAIMS-SPARSE · TYPE-USCORP · VEL-DROP · BOOK-RICH
- GRANTS-MICRO 13 grants
- MID-PACK #21,680/49,997
- PHOTO-FINISH RedShift BioAnalytics
- CPC-UNK CPC blank
- INNOV-LOW 9.7/100
- CLAIMS-SPARSE 1.0 claims/avg
- TYPE-USCORP US Corporation
- VEL-DROP -100% vel
- BOOK-RICH 9/10 fields
Nearest grant-volume peer: RedShift BioAnalytics Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Relamp’s 9.7 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Relamp
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Relamp · this assignee 10
Relamp · this assignee
10 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Relamp's Innovation Score is 9.7/100 (1st percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Relamp?
Each dot is one of Relamp’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Relamp’s own 1.0 claims/patent is at or below the 21.4 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.
Where Relamp's grants concentrate
Relamp is a focused PatentsView assignee: 0 CPC subclasses . By volume, Relamp sits between RedShift BioAnalytics Inc. and Respiratory Motion, Inc..
Who files at Relamp's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Redshift Bioanaly…
RedShift BioAnalytics Inc.
13 patents
- Redwood Robotics
Redwood Robotics Inc.
13 patents
- Refratechnik Hold…
Refratechnik Holding GmbH
13 patents
- Regenlab USA
RegenLab USA LLC
13 patents
- Relay Therapeutics
Relay Therapeutics, Inc.
13 patents
- Relypsa
Relypsa, Inc.
13 patents
- Renovia
Renovia Inc.
13 patents
- Respiratory Motion
Respiratory Motion, Inc.
13 patents
- Relamp ◀
Relamp
13 patents
What this shows Relamp holds 13 patents at rank #21,693, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Relamp
By rank, the assignees closest to #21,693 in granted patent volume.
- RedShift BioAnalytics Inc. #21,689 · 13 patents
- Redwood Robotics Inc. #21,690 · 13 patents
- Refratechnik Holding GmbH #21,691 · 13 patents
- RegenLab USA LLC #21,692 · 13 patents
- Relay Therapeutics, Inc. #21,694 · 13 patents
- Relypsa, Inc. #21,695 · 13 patents
- Renovia Inc. #21,696 · 13 patents
- Respiratory Motion, Inc. #21,697 · 13 patents
Relamp's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
10 1st percentile higher than 1% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2019 | 13 | 100.0% |
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Relamp's patent record in context - here's where to go next.
- Ranked #21,680 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Relamp against RedShift BioAnalytics Inc., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 9.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.